Ardelyx Inc. [NASDAQ: ARDX] slipped around 0.0 points on Thursday, while shares priced at $6.83 at the close of the session, down 0.00%. The company report on May 6, 2021 that Ardelyx Reports First Quarter 2021 Financial Results and Recent Business Highlights.
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, reported business highlights and financial results for the first quarter ended March 31, 2021.
“We continue to prepare for the potential approval and launch of tenapanor following the recent extension of our PDUFA date to July 29, 2021,” said Mike Raab, president and chief executive officer of Ardelyx. “We remain confident in the comprehensive data included in our New Drug Application and believe tenapanor represents an attractive alternative to currently available therapies to control serum phosphorus in CKD patients on dialysis. To that end, we are committed to working with the FDA through the completion of its review of our NDA and look forward to the possibility of making a significant impact in the lives of patients.”.
Ardelyx Inc. stock is now 5.56% up from its year-to-date (YTD) trading value. ARDX Stock saw the intraday high of $7.78 and lowest of $6.66 per share. The company’s 52-week high price is 9.23, which means current price is +15.57% above from all time high which was touched on 04/15/21.
Compared to the average trading volume of 2.14M shares, ARDX reached a trading volume of 4668392 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Ardelyx Inc. [ARDX]?
Wedbush have made an estimate for Ardelyx Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 23, 2021. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on January 06, 2021, representing the official price target for Ardelyx Inc. stock. Previously, the target price had yet another raise to $13, while Citigroup analysts kept a Buy rating on ARDX stock.
The Average True Range (ATR) for Ardelyx Inc. is set at 0.54, with the Price to Sales ratio for ARDX stock in the period of the last 12 months amounting to 51.10. The Price to Book ratio for the last quarter was 5.06, with the Price to Cash per share for the same quarter was set at 1.85.
How has ARDX stock performed recently?
Ardelyx Inc. [ARDX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.86. With this latest performance, ARDX shares dropped by -17.21% in over the last four-week period, additionally plugging by 20.25% over the last 6 months – not to mention a drop of -15.78% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ARDX stock in for the last two-week period is set at 44.00, with the RSI for the last a single of trading hit 42.66, and the three-weeks RSI is set at 45.70 for Ardelyx Inc. [ARDX]. The present Moving Average for the last 50 days of trading for this stock 7.24, while it was recorded at 6.83 for the last single week of trading, and 6.45 for the last 200 days.
Ardelyx Inc. [ARDX]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Ardelyx Inc. [ARDX] shares currently have an operating margin of -1199.05 and a Gross Margin at +45.63. Ardelyx Inc.’s Net Margin is presently recorded at -1245.71.
Return on Total Capital for ARDX is now -43.15, given the latest momentum, and Return on Invested Capital for the company is -45.93. Return on Equity for this stock declined to -60.31, with Return on Assets sitting at -40.89. When it comes to the capital structure of this company, Ardelyx Inc. [ARDX] has a Total Debt to Total Equity ratio set at 42.28. Additionally, ARDX Total Debt to Total Capital is recorded at 29.72, with Total Debt to Total Assets ending up at 26.45. Long-Term Debt to Equity for the company is recorded at 37.30, with the Long-Term Debt to Total Capital now at 26.21.
Reflecting on the efficiency of the workforce at the company, Ardelyx Inc. [ARDX] managed to generate an average of -$731,109 per employee. Receivables Turnover for the company is 20.19 with a Total Asset Turnover recorded at a value of 0.03.Ardelyx Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.90 and a Current Ratio set at 4.90.
Earnings analysis for Ardelyx Inc. [ARDX]
With the latest financial reports released by the company, Ardelyx Inc. posted -0.28/share EPS, while the average EPS was predicted by analysts to be reported at -0.26/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -7.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ARDX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Ardelyx Inc. go to 30.00%.
Insider trade positions for Ardelyx Inc. [ARDX]
There are presently around $578 million, or 83.10% of ARDX stock, in the hands of institutional investors. The top three institutional holders of ARDX stocks are: NEA MANAGEMENT COMPANY, LLC with ownership of 13,633,582, which is approximately 0% of the company’s market cap and around 1.30% of the total institutional ownership; RA CAPITAL MANAGEMENT, L.P., holding 6,077,294 shares of the stock with an approximate value of $41.51 million in ARDX stocks shares; and BLACKROCK INC., currently with $40.86 million in ARDX stock with ownership of nearly 1.018% of the company’s market capitalization.
Positions in Ardelyx Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 60 institutional holders increased their position in Ardelyx Inc. [NASDAQ:ARDX] by around 7,503,900 shares. Additionally, 48 investors decreased positions by around 3,143,759 shares, while 28 investors held positions by with 73,980,898 shares. The mentioned changes placed institutional holdings at 84,628,557 shares, according to the latest SEC report filing. ARDX stock had 14 new institutional investments in for a total of 1,287,374 shares, while 10 institutional investors sold positions of 251,034 shares during the same period.